BNP Paribas Aktienanleihe SNW 27..../ DE000PG7B8P2 /
07.01.2025 9:53:13 | Изменение+1.16 | Бид22:00:27 | Предложение22:00:27 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
96.19EUR | +1.22% | - Величина цены спроса: - |
- Величина цены предложения: - |
SANOFI SA INHABER ... | 100.00 EUR | 27.03.2025 | Call |
GlobeNewswire
02.09.2024
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire
26.08.2024
Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire
14.08.2024
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire
13.08.2024
Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
12.08.2024
MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire
08.08.2024
Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire
06.08.2024
Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire
01.08.2024
Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
31.07.2024
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire
25.07.2024
Press Release: Online availability of Sanofi’s half-year financial report for 2024
GlobeNewswire
25.07.2024
Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница